Sub-Total: $0.00
Emerging Interleukin5 (IL5) Antagonists Based Therapies for Eosinophilic Asthma
Complimentary
Related products
-
Advances in the Understanding of Etiology, Evaluation, and Management of Neurotrophic Keratitis
Read more -
Sustained-Release Drug Delivery System in the Management of Glaucoma
Read more -
Emerging Treatment Options for Pustular Psoriasis
Read more -
Advances in Blood-based Biomarkers and Disease-Modifying Anti-Amyloid Antibody Therapies for Early-Stage Alzheimer’s Disease
Read more
